Search

Press release

Evonik introduces TEGO® Betain P 50 C - The cost-efficient, concentrated Cocamidopropyl Betaine based on RSPO certified palm kernel oil

Essen, March 16, 2015
  • The new 38% active betaine provides superior thickening which can reduce the formulation cost.

  • The easily processable secondary surfactant can be used in a wide range of surfactant systems delivering excellent foam and improved mildness.


Nowadays, cosmetics producers and end consumers are more and more looking for cost-effective and mild cleansing products with excellent foaming and pleasing rheological properties. Additionally, there is a growing global demand for responsibly sourced feedstocks.

Based on these requirements Evonik, a global leader in the secondary surfactant market and supporter of responsible care, launches TEGO®Betain P 50 C (INCI: Cocamidopropyl Betaine), a novel concentrated surfactant based on RSPO certified sustainable palm kernel oil. Due to its exceptional thickening performance, it provides an improved cost/performance ratio compared to standard CAPBs. Furthermore, the 38% active betaine is easy to process and delivers generous foam combined with a pleasant skinfeel. 

The predominantly renewable, RSPO-certified palm-based feedstock and the high product purity of the preservative-free TEGO® Betain P 50 C support a more environmentally conscious approach in the cosmetic industry.

TEGO® Betain P 50 C is suitable for a broad range of application formats in the cleansing care market, including body washes, shampoos, liquid soaps, foam baths, oral care and soap bars. 

With TEGO® Betain P 50 C, Evonik introduces a cost-efficient, concentrated Cocoamidopropyl Betaine based on RSPO certified sustainable palm kernel oil.

Downloads

Contact

Lisa Dierks

Global Marketing Communication Manager / Personal Care

  • Company information

    Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

    Evonik is active in over 100 countries around the world. In fiscal 2014 more than 33,000 employees generated sales of around €12.9 billion and an operating profit (adjusted EBITDA) of about €1.9 billion.

  • Disclaimer

    In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.